Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 1
1999 3
2000 3
2001 4
2002 3
2003 4
2004 11
2005 9
2006 17
2007 13
2008 13
2009 13
2010 22
2011 27
2012 25
2013 27
2014 31
2015 17
2016 24
2017 16
2018 10
2019 16
2020 17
2021 9
2022 11
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.
Ferragut F, Vachetta VS, Troncoso MF, Rabinovich GA, Elola MT. Ferragut F, et al. Cytokine Growth Factor Rev. 2021 Oct;61:27-37. doi: 10.1016/j.cytogfr.2021.07.001. Epub 2021 Jul 9. Cytokine Growth Factor Rev. 2021. PMID: 34272152 Review.
Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a glycoprotein involved in homotypic and heterotypic cell adhesion. ...Finally, we highlight the role of ALCAM as a cancer stem cell marker and
Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a glycoprotein involved in homo
ALCAM/CD166: cancer-related issues.
Weidle UH, Eggle D, Klostermann S, Swart GW. Weidle UH, et al. Cancer Genomics Proteomics. 2010 Sep-Oct;7(5):231-43. Cancer Genomics Proteomics. 2010. PMID: 20952758 Review.
Activated leucocyte adhesion molecule (ALCAM) was originally identified as a transmembrane receptor which is involved in T-cell activation and has other still unresolved functions in hematopoiesis, development, inflammation and transendothelial migrati …
Activated leucocyte adhesion molecule (ALCAM) was originally identified as a transmembrane receptor which is involved i …
ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles.
Cardeñes B, Clares I, Bezos T, Toribio V, López-Martín S, Rocha A, Peinado H, Yáñez-Mó M, Cabañas C. Cardeñes B, et al. Int J Mol Sci. 2022 May 20;23(10):5753. doi: 10.3390/ijms23105753. Int J Mol Sci. 2022. PMID: 35628559 Free PMC article.
We established that the adhesion molecule ALCAM/CD166 is involved in the interaction of cancer-derived EVs with recipient cancer cells (a process termed "EV binding" or "EV docking") and in their subsequent uptake by these cells. The identification of …
We established that the adhesion molecule ALCAM/CD166 is involved in the interaction of cancer-derived EVs with …
The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers.
Yang Y, Sanders AJ, Dou QP, Jiang DG, Li AX, Jiang WG. Yang Y, et al. Cancers (Basel). 2021 Oct 15;13(20):5187. doi: 10.3390/cancers13205187. Cancers (Basel). 2021. PMID: 34680335 Free PMC article. Review.
Activated leukocyte cell adhesion molecule (ALCAM), also known as CD166, is a cell adhesion protein that is found in multiple cell types. ALCAM has multiple and diverse roles in various physiological and
Activated leukocyte cell adhesion molecule (ALCAM), also known as CD166, is a cell
Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.
von Lersner A, Droesen L, Zijlstra A. von Lersner A, et al. Clin Exp Metastasis. 2019 Apr;36(2):87-95. doi: 10.1007/s10585-019-09957-2. Epub 2019 Feb 18. Clin Exp Metastasis. 2019. PMID: 30778704 Free PMC article. Review.
In epithelial-derived cancers, altered regulation of cell-cell adhesion facilitates the disruption of tissue cohesion that is central to the progression to malignant disease. Although numerous intercellular adhesion molecules participate in epithelial …
In epithelial-derived cancers, altered regulation of cell-cell adhesion facilitates the disruption of tissue cohesion t …
CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivity.
von Bauer R, Oikonomou D, Sulaj A, Mohammed S, Hotz-Wagenblatt A, Gröne HJ, Arnold B, Falk C, Luethje D, Erhardt A, Stern DM, Bierhaus A, Nawroth PP. von Bauer R, et al. J Immunol. 2013 Jul 1;191(1):369-77. doi: 10.4049/jimmunol.1201864. Epub 2013 May 31. J Immunol. 2013. PMID: 23729438 Free PMC article.
This has led to the hypothesis that molecules scavenged by soluble RAGE bind to receptors other than RAGE. This study identifies CD166/ALCAM (ALCAM) as a close structural and functional homolog of RAGE, and it shows that binding of S100B to CD166/AL
This has led to the hypothesis that molecules scavenged by soluble RAGE bind to receptors other than RAGE. This study identifies CD166
ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.
Gilsanz A, Sánchez-Martín L, Gutiérrez-López MD, Ovalle S, Machado-Pineda Y, Reyes R, Swart GW, Figdor CG, Lafuente EM, Cabañas C. Gilsanz A, et al. Cell Mol Life Sci. 2013 Feb;70(3):475-93. doi: 10.1007/s00018-012-1132-0. Epub 2012 Sep 30. Cell Mol Life Sci. 2013. PMID: 23052204 Free PMC article.
ALCAM/CD166 is a member of the immunoglobulin superfamily of cell adhesion molecules (Ig-CAMs) which mediates intercellular adhesion through either homophilic (ALCAM-ALCAM) or heterophilic (ALCAM-CD6) interactions. ...The fu
ALCAM/CD166 is a member of the immunoglobulin superfamily of cell adhesion molecules (Ig-CAMs) which mediates in
Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
Swart GW. Swart GW. Eur J Cell Biol. 2002 Jun;81(6):313-21. doi: 10.1078/0171-9335-00256. Eur J Cell Biol. 2002. PMID: 12113472 Review.
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a member of the immunoglobulin superfamily and belongs to a recent subgroup with five extracellular immunoglobulin-like domains (VVC2C2C2). ALCAM mediates both hete
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a member of the immunoglobulin
Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism.
Yang Y, Sanders AJ, Ruge F, Dong X, Cui Y, Dou QP, Jia S, Hao C, Ji J, Jiang WG. Yang Y, et al. Am J Cancer Res. 2021 Dec 15;11(12):5917-5932. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018233 Free PMC article.
Activated leukocyte cell adhesion molecule (ALCAM, or CD166) is a cell adhesion molecule and one of potential tumour metastasis 'soil' receptors that via homotypic and heterotypic interactions, mediates cancer
Activated leukocyte cell adhesion molecule (ALCAM, or CD166) is a cell adhesion
ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A, Matysiak W, Motyl T. Jezierska A, et al. Med Sci Monit. 2006 Aug;12(8):BR263-73. Epub 2006 Jul 12. Med Sci Monit. 2006. PMID: 16865058
BACKGROUND: Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a 105-kDa transmembrane glycoprotein linked with cell migration and development and with cancer progression (malignant melanoma, prostate cancer and, ve …
BACKGROUND: Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a 105-kDa transmemb …
326 results